rrr
Research institute for biological safety problems

QazCoVac-P – COVID-19 SUBUNIT VACCINE IS ON THE WHO LIST OF CANDIDATE VACCINES FOR PHASE 1/2 CLINICAL TRIALS

On June 22, 2021, Kazakhstan’s second COVID-19 vaccine QazCoVac-P (subunit) was officially included in the list of candidate vaccines of the World Health Organization for conducting phase 1/2 clinical trials.

https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

Earlier, on June 18, 2021, the design of the clinical trial was officially posted on the website ClinicalTrials.gov under Identifier number: NCT04930003

https://clinicaltrials.gov/ct2/show/NCT04930003?term=vaccine&recrs=adf&cond=COVID-19&phase=0123&sort=nwst&draw=2